Thus, in COVID-19 the viral inflammatory and immune responses can impair insulin sensitivity and dysregulate glucose metabolism, leading to a vicious cycle of hyperglycemia and inflammatory response that destroys tissue integrity and physiological function during the critical stages of infection. The gene discussed is INS; the disease is Hyperglycemia.